Skip to main content
. 2018 May 2;9(7):775–784. doi: 10.1111/1759-7714.12643

Figure 5.

Figure 5

CCL4 expression was associated with survival in patients with lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD). (a) There was no correlation between CCL4 expression and overall survival (OS) in patients with LUSC (P = 0.22). (b) High levels of CCL4 were associated with good progression‐free survival (PFS) (P = 0.021) in LUSC patients. However, in LUAD patients, high CCL4 expression indicated (c) poor OS (P = 0.013), (d) but not PFS (P = 0.077).